Genetics is about everybody
Randy Scott, biochemist and Invitae co-founder
Randy Scott talks about his family experience with rare genetic disorders and how it has helped shape Invitae’s mission: aggregate all the world’s genetic tests, lower the cost of genetic testing so that it’s affordable and accessible to nearly everyone, and fundamentally change healthcare.
Getting answers more quickly
Invitae genetic counselor Erynn Gordon on multi-gene testing for hereditary cancer syndromes
Erynn Gordon, genetic counselor at Invitae, explains how multi-gene panels have changed the landscape of genetic testing for hereditary cancer syndromes. Multi-gene panels enable healthcare providers to investigate syndromes at the same time, instead of taking several tests and waiting for the results each time. This means clinicians get answers more quickly and increases the…
Giving more patients access
Invitae’s Dr. Federico Monzon explains how multi-gene tests are speeding diagnoses and making genetic testing more accessible
Genetic testing used to be done one gene at a time. Thanks to technological advances, many genes can now be tested at once. Dr. Monzon, a molecular pathologist, explains how multi-gene testing reduces the time it takes to get a diagnosis, and how new technology lowers costs and enables more patients to access genetic testing.
Invitae is pleased to offer scholarships for NSGC’s 2014 Annual Education Conference
Invitae is excited to be able to offer scholarships to ten (10) Full or New Genetic Counselor Members of NSGC to attend the National Society of Genetic Counselors 2014 Annual Education Conference (AEC). Scholarship recipients will receive complimentary full registration (including CEU fee) and a travel stipend of $570. Drawing together thousands of genetic counselors, the…
Is better patient care dependent on sharing genetic data?
Invitae scientist John Garcia on reducing VUS rates through data sharing
The inevitable fall of VUS rates There has been a lot of discussion recently about the rate of Variants of Uncertain Significance (VUSs) in the field of genetic testing. The fact is that some VUSs are unavoidable in genetic testing; every patient has a background rate of genetic variants that cannot be definitively interpreted at…
Genome management? The rise of genome factories? A personal “Omics” cloud? A match.com for clinical trials?
Invitae’s Ruby Gadelrab on the audacious and achievable goals discussed at PMWC2014.
Over the course of two days last week, thought leaders from across multiple industries assembled at the Computer History Museum in Silicon Valley to discuss key themes in personalized medicine at the Personalized Medicine World Conference 2014 (PMWC). Having been in the genomics space for over 17 years and as now part of team that leads…
What does it take to make next-generation sequencing truly clinical?
Jon Sorensen, Invitae bioinformatician
Like many people deeply immersed in DNA sequencing, my first introduction to next-generation sequencing was a packed, standing-room only panel discussion at the 2003 Genomes, Medicine and Environment conference (née GSAC). It was two years before any NGS instrument was commercially available, and yet we had all gathered there because—although that year the price of…
Are physicians ready for the tsunami of genetic information that is headed towards the medical community?
Jill Hagenkord on the upcoming impact of genetic data on patient care
Adapt or Perish: Why All Doctors Will Need To Be Geneticists Earlier this month our Co-founder Randy Scott, posted a blog where he talks about moving from a world of Genetic Scarcity to a world of Genetic abundance. What are the implications for medical community? Lets face it, doctors don’t really know much genetics. Yes, we…
Can sharing your genetic information save a life or accelerate a cure?
Randy Scott, Invitae co-founder, describes Invitae’s mission
Last week, the world took a huge step forward toward a new era of personalized medicine when the Supreme Court ruled that naturally occurring DNA cannot be patented. We applaud the Supreme Court decision. Now that we have the freedom to test all genes known to cause a hereditary disorder, we need to Free the…